tradingkey.logo
tradingkey.logo
Search

BridgeBio Pharma Inc

BBIO
Add to Watchlist
84.030USD
+1.100+1.33%
Close 07-23 16:00ETQuotes delayed by 15 min
16.45BMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Kohlberg Kravis Roberts & Co. L.P.
6.77%
BlackRock Institutional Trust Company, N.A.
6.16%
Viking Global Investors LP
6.05%
Janus Henderson Investors
5.62%
Farallon Capital Management, L.L.C.
4.59%
Other
70.81%
Shareholders
Shareholders
Proportion
Kohlberg Kravis Roberts & Co. L.P.
6.77%
BlackRock Institutional Trust Company, N.A.
6.16%
Viking Global Investors LP
6.05%
Janus Henderson Investors
5.62%
Farallon Capital Management, L.L.C.
4.59%
Other
70.81%
Shareholder Types
Shareholders
Proportion
Investment Advisor
36.99%
Investment Advisor/Hedge Fund
35.07%
Hedge Fund
13.21%
Private Equity
8.58%
Individual Investor
3.92%
Research Firm
3.06%
Venture Capital
1.32%
Sovereign Wealth Fund
0.78%
Pension Fund
0.46%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
793
195.09M
99.61%
-1.32M
2025Q4
692
193.26M
104.83%
+271.46K
2025Q3
709
193.09M
107.21%
-2.36M
2025Q2
651
195.61M
105.27%
+8.34M
2025Q1
612
193.54M
102.70%
-1.78M
2024Q4
570
182.80M
101.77%
+5.04M
2024Q3
551
177.77M
103.84%
-1.98M
2024Q2
526
180.27M
100.67%
+2.80M
2024Q1
514
177.44M
98.44%
-3.39M
2023Q4
509
170.23M
101.76%
+4.36M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Kohlberg Kravis Roberts & Co. L.P.
13.26M
6.84%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
12.07M
6.23%
+152.45K
+1.28%
Dec 31, 2025
Viking Global Investors LP
13.03M
6.72%
-1.37M
-9.50%
Feb 13, 2026
Janus Henderson Investors
11.00M
5.67%
+2.26M
+25.85%
Dec 31, 2025
Farallon Capital Management, L.L.C.
9.00M
4.64%
+806.46K
+9.84%
Dec 31, 2025
Kumar (Neil)
6.18M
3.19%
+5.67K
+0.09%
Feb 19, 2026
Aisling Capital Management LP
5.09M
2.63%
-1.00M
-16.42%
Dec 31, 2025
State Street Investment Management (US)
4.96M
2.56%
-643.47K
-11.48%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Tema Oncology ETF
5.74%
Franklin Genomic Advancements ETF
4.69%
Invesco Dorsey Wright Healthcare Momentum ETF
2.6%
Virtus LifeSci Biotech Products ETF
2.53%
State Street SPDR S&P Biotech ETF
2.32%
Tema Heart & Health ETF
2.06%
ProShares Ultra Nasdaq Biotechnology
1.67%
Direxion Daily S&P Biotech Bull 3X Shares
1.43%
iShares Health Innovation Active ETF
1.36%
Invesco Nasdaq Biotechnology ETF
1.17%
View more
Tema Oncology ETF
Proportion5.74%
Franklin Genomic Advancements ETF
Proportion4.69%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion2.6%
Virtus LifeSci Biotech Products ETF
Proportion2.53%
State Street SPDR S&P Biotech ETF
Proportion2.32%
Tema Heart & Health ETF
Proportion2.06%
ProShares Ultra Nasdaq Biotechnology
Proportion1.67%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion1.43%
iShares Health Innovation Active ETF
Proportion1.36%
Invesco Nasdaq Biotechnology ETF
Proportion1.17%
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.